Entries by Tina Dackemark Lawesson

Winner of the MDCPSS Best Overall Abstract Award at 2021 SOT!🏅

At this year’s Society of Toxicology annual meeting SenzaGen’s in vitro Medical Device test method was awarded the Best Overall Abstract Award in the Medical Device and Combination Product Specialty Section. Authors Joshua J. Schmidt, Ph.D. Ron Brown Rose-Marie Jenvert, PhD Abstract 3020: Poster Board – P158: Applicability Domain of the GARDskin Medical Device Test […]

Join SenzaGen’s hosted session at 2021 SOT

Are you attending the 2021 SOT Annual Meeting and ToxExpo? Come join our workshop presentation, hosted session and poster presentations to hear the latest news about GARD™ and how the assays are used for skin sensitization testing! Click image for more details about the program!  

Season’s greetings from all of us at SenzaGen

We wish you a truly happy holiday season, and we look forward to seeing you again in the new year. 2020 Highlights SenzaGen received GLP approval We can now offer GLP-compliant test services using the GARD™platform. Read more   GARD™skin Dose-Response This newly released assay provides quantitative potency information related to skin sensitization. Learn more […]

RIFM Principle Scientist Gretchen Ritacco speaks about SenzaGen and RIFM collaboration

Here is an interview with Principal Scientist Gretchen Ritacco, MS, explaining why RIFM has focused some of its research on the potential for light to activate fragrance materials resulting in reactions in the body’s largest organ, the skin. Since June 2020, SenzaGen and the Research Institute for Fragrance Materials (RIFM) are collaborating to investigate in […]